Showing results (281-290 of 301) with videos related to
Sort By:
Pageof 31
Epilepsia Open|May 29, 2024
A cross-sectional, multicenter survey of the prevalence and influencing factors for migraine in epilepsyWenyan Shi, Hanlin Sun, Wei Peng, et al.Therapeutic Advances in Neurological Disorders|September 4, 2023
Prevalence and risk factors of anxiety and depression in adult patients with epilepsy: a multicenter survey-based studyWenyan Shi, Hanlin Sun, Wei Peng, et al.Nature|December 4, 2012
Ca2+ regulates T-cell receptor activation by modulating the charge property of lipidsXiaoshan Shi, Yunchen Bi, Wei Yang, et al.Journal of Medicinal Chemistry|December 1, 2022
Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon CancerXing Li, Shanlin Yang, Honghan Zhang, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 12, 2024
Effects of the Thiol Methyltransferase Inhibitor (±)-2,3-Dichloro-α-Methylbenzylamine (DCMB) on the Pharmacokinetics and Metabolism of Vicagrel in RatsCheng Yang, Jingru Gong, Mingzhen Xue, et al.Nature Communications|December 5, 2023
Collaborative and privacy-preserving retired battery sorting for profitable direct recycling via federated machine learningShengyu Tao, Haizhou Liu, Chongbo Sun, et al.Journal of Medicinal Chemistry|March 11, 2024
Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune ActivityLiu Liu, Honghan Zhang, Jie Hou, et al.British Journal of Clinical Pharmacology|April 9, 2020
Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y12 inhibitorYifan Zhang, Xiaoxue Zhu, Yan Zhan, et al.Journal of Medicinal Chemistry|June 4, 2008
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studiesXiaoan Wen, Hongbin Sun, Jun Liu, et al.European Heart Journal. Cardiovascular Pharmacotherapy|April 19, 2022
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary interventionXin Zhao, Sicong Ma, Yi Kang, et al.Pageof 31